111 related articles for article (PubMed ID: 9616526)
21. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
22. Incremental benefit of adding oxitropium bromide to formoterol in patients with stable COPD.
Cazzola M; Di Perna F; Califano C; Vinciguerra A; D'Amato M
Pulm Pharmacol Ther; 1999; 12(4):267-71. PubMed ID: 10501652
[TBL] [Abstract][Full Text] [Related]
23. Bronchodilator responsiveness in patients with COPD.
Tashkin DP; Celli B; Decramer M; Liu D; Burkhart D; Cassino C; Kesten S
Eur Respir J; 2008 Apr; 31(4):742-50. PubMed ID: 18256071
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
Ulrik CS
Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
[TBL] [Abstract][Full Text] [Related]
25. A comparison of regular with intermittent bronchodilators in asthma patients on inhaled steroids.
Tormey VJ; Faul J; Leonard C; Lennon A; Burke CM
Ir J Med Sci; 1997; 166(4):249-52. PubMed ID: 9394077
[TBL] [Abstract][Full Text] [Related]
26. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
[TBL] [Abstract][Full Text] [Related]
27. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
Bateman ED; van Dyk M; Sagriotis A
Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
[TBL] [Abstract][Full Text] [Related]
28. Effects of corticosteroids on bronchodilator action in chronic obstructive lung disease.
Wempe JB; Postma DS; Breederveld N; Kort E; van der Mark TW; Koëter GH
Thorax; 1992 Aug; 47(8):616-21. PubMed ID: 1412119
[TBL] [Abstract][Full Text] [Related]
29. The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests.
Oga T; Nishimura K; Tsukino M; Hajiro T; Ikeda A; Izumi T
Am J Respir Crit Care Med; 2000 Jun; 161(6):1897-901. PubMed ID: 10852763
[TBL] [Abstract][Full Text] [Related]
30. Oxygen desaturation and breathlessness during corridor walking in chronic obstructive pulmonary disease: effect of oxitropium bromide.
Spence DP; Hay JG; Carter J; Pearson MG; Calverley PM
Thorax; 1993 Nov; 48(11):1145-50. PubMed ID: 8296259
[TBL] [Abstract][Full Text] [Related]
31. Oxitropium bromide, a new anticholinergic bronchodilator.
Skorodin MS; Gross NJ; Moritz T; King FW; Armstrong W; Wells D; Galavan E; Slutsky L
Ann Allergy; 1986 Mar; 56(3):229-32. PubMed ID: 3513670
[TBL] [Abstract][Full Text] [Related]
32. Tolerance to beta 2-agonists in patients with chronic obstructive pulmonary disease.
Georgopoulos D; Wong D; Anthonisen NR
Chest; 1990 Feb; 97(2):280-4. PubMed ID: 1967572
[TBL] [Abstract][Full Text] [Related]
33. Effect of oral prednisolone on response to salbutamol and ipratropium bromide aerosols in patients with chronic airflow obstruction.
Curzon PG; Martin MA; Cooke NJ; Muers MF
Thorax; 1983 Aug; 38(8):601-4. PubMed ID: 6225214
[TBL] [Abstract][Full Text] [Related]
34. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Aaron SD; Vandemheen KL; Fergusson D; Maltais F; Bourbeau J; Goldstein R; Balter M; O'Donnell D; McIvor A; Sharma S; Bishop G; Anthony J; Cowie R; Field S; Hirsch A; Hernandez P; Rivington R; Road J; Hoffstein V; Hodder R; Marciniuk D; McCormack D; Fox G; Cox G; Prins HB; Ford G; Bleskie D; Doucette S; Mayers I; Chapman K; Zamel N; FitzGerald M;
Ann Intern Med; 2007 Apr; 146(8):545-55. PubMed ID: 17310045
[TBL] [Abstract][Full Text] [Related]
35. [The bronchodilator effect of aerosol beta-2-mimetic and anticholinergic agents in patients with chronic bronchitis].
Vestri R; Philip-Joet F; Reynaud-Gaubert M; Arnaud A
Rev Mal Respir; 1990; 7(1):59-63. PubMed ID: 2251437
[TBL] [Abstract][Full Text] [Related]
36. Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.
Nisar M; Walshaw M; Earis JE; Pearson MG; Calverley PM
Thorax; 1990 Mar; 45(3):190-4. PubMed ID: 2330551
[TBL] [Abstract][Full Text] [Related]
37. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials.
Fabbri LM; Calverley PM; Izquierdo-Alonso JL; Bundschuh DS; Brose M; Martinez FJ; Rabe KF;
Lancet; 2009 Aug; 374(9691):695-703. PubMed ID: 19716961
[TBL] [Abstract][Full Text] [Related]
38. Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. A 4-year prospective study.
Dompeling E; van Schayck CP; van Grunsven PM; van Herwaarden CL; Akkermans R; Molema J; Folgering H; van Weel C
Ann Intern Med; 1993 May; 118(10):770-8. PubMed ID: 8470851
[TBL] [Abstract][Full Text] [Related]
39. Long-term treatment benefits with tiotropium in COPD patients with and without short-term bronchodilator responses.
Tashkin D; Kesten S
Chest; 2003 May; 123(5):1441-9. PubMed ID: 12740259
[TBL] [Abstract][Full Text] [Related]
40. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
Pillet O; Manier G; Castaing Y
Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
